deltatrials

Pancreatic ductal adenocarcinoma Trials in Los Angeles, United States

Conditions / Pancreatic ductal adenocarcinoma / Los Angeles, United States

Clinical trials for Pancreatic ductal adenocarcinoma investigate a range of treatment strategies and patient populations.

32 total trials for this combination

Showing top 10 of 32 trials

Trials

NCT ID Title Status Phase
NCT04913337 Study of NGM707 As Monotherapy and in Combination with Pembrolizumab in Advanced or Metastatic Solid Tumor Malignancies ACTIVE_NOT_RECRUITING PHASE1/PHASE2
NCT05563272 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors TERMINATED PHASE2
NCT06586515 MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors RECRUITING PHASE1
NCT06562192 Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers RECRUITING
NCT04025216 A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers TERMINATED PHASE1
NCT06305247 A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours RECRUITING
NCT05641896 Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers COMPLETED PHASE2
NCT04657068 A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors RECRUITING PHASE1/PHASE2
NCT01013649 Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery COMPLETED PHASE3
NCT04853017 A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors COMPLETED PHASE1

Related Pages